Assessment of the predictive capacity of a physiologically based kinetic model using a read-across approach.
Analogues
Kinetics
PBK model
Read-across
Risk assessment
Journal
Computational toxicology (Amsterdam, Netherlands)
ISSN: 2468-1113
Titre abrégé: Comput Toxicol
Pays: Netherlands
ID NLM: 101708081
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
01
08
2020
revised:
02
02
2021
accepted:
03
02
2021
entrez:
24
5
2021
pubmed:
25
5
2021
medline:
25
5
2021
Statut:
ppublish
Résumé
With current progress in science, there is growing interest in developing and applying Physiologically Based Kinetic (PBK) models in chemical risk assessment, as knowledge of internal exposure to chemicals is critical to understanding potential effects in vivo. In particular, a new generation of PBK models is being developed in which the model parameters are derived from in silico and in vitro methods. To increase the acceptance and use of these "Next Generation PBK models", there is a need to demonstrate their validity. However, this is challenging in the case of data-poor chemicals that are lacking in kinetic data and for which predictive capacity cannot, therefore, be assessed. The aim of this work is to lay down the fundamental steps in using a read across framework to inform modellers and risk assessors on how to develop, or evaluate, PBK models for chemicals without in vivo kinetic data. The application of a PBK model that takes into account the absorption, distribution, metabolism and excretion characteristics of the chemical reduces the uncertainties in the biokinetics and biotransformation of the chemical of interest. A strategic flow-charting application, proposed herein, allows users to identify the minimum information to perform a read-across from a data-rich chemical to its data-poor analogue(s). The workflow analysis is illustrated by means of a real case study using the alkenylbenzene class of chemicals, showing the reliability and potential of this approach. It was demonstrated that a consistent quantitative relationship between model simulations could be achieved using models for estragole and safrole (source chemicals) when applied to methyleugenol (target chemical). When the PBK model code for the source chemicals was adapted to utilise input values relevant to the target chemical, simulation was consistent between the models. The resulting PBK model for methyleugenol was further evaluated by comparing the results to an existing, published model for methyleugenol, providing further evidence that the approach was successful. This can be considered as a "read-across" approach, enabling a valid PBK model to be derived to aid the assessment of a data poor chemical.
Identifiants
pubmed: 34027243
doi: 10.1016/j.comtox.2021.100159
pii: S2468-1113(21)00007-4
pmc: PMC8130669
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100159Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Toxicology. 2017 Dec 1;392:119-129
pubmed: 28288858
Altern Lab Anim. 2020 Jul;48(4):146-172
pubmed: 33119417
Toxicol Sci. 2000 Mar;54(1):71-80
pubmed: 10746933
Chem Res Toxicol. 2007 Jul;20(7):991-8
pubmed: 17590023
Environ Health Perspect. 2004 May;112(6):678-80
pubmed: 15121510
Mutat Res. 2005 Jul 1;574(1-2):124-38
pubmed: 15914212
Curr Drug Metab. 2007 Jan;8(1):33-45
pubmed: 17266522
Arch Toxicol. 2017 Sep;91(9):3093-3108
pubmed: 28357488
Toxicol Ind Health. 1997 Jul-Aug;13(4):407-84
pubmed: 9249929
Toxicol Appl Pharmacol. 2012 May 1;260(3):271-84
pubmed: 22445790
Toxicol Sci. 2012 Aug;128(2):301-16
pubmed: 22588462
Mutagenesis. 2012 Nov;27(6):653-63
pubmed: 22844077
Regul Toxicol Pharmacol. 2018 Nov;99:5-21
pubmed: 30144470
ALTEX. 2016;33(2):149-66
pubmed: 26863606
PLoS Comput Biol. 2016 Feb 12;12(2):e1004495
pubmed: 26871706
Regul Toxicol Pharmacol. 2019 Feb;101:121-134
pubmed: 30468762
Regul Toxicol Pharmacol. 2018 Nov;99:61-77
pubmed: 30201539
Regul Toxicol Pharmacol. 2017 Nov;90:104-115
pubmed: 28866268
Biotechnol Prog. 1999 May-Jun;15(3):540-55
pubmed: 10356275
Arch Toxicol. 2017 Feb;91(2):713-734
pubmed: 27334372
Drug Metab Dispos. 1985 Jan-Feb;13(1):42-50
pubmed: 2858375
Xenobiotica. 1987 Oct;17(10):1223-32
pubmed: 3424869
Regul Toxicol Pharmacol. 2020 Jul;114:104667
pubmed: 32387187
Toxicol Appl Pharmacol. 2008 Sep 1;231(2):248-59
pubmed: 18539307
Comput Toxicol. 2019 Feb;9:61-72
pubmed: 31008414
Food Chem Toxicol. 2016 Mar;89:138-50
pubmed: 26826679
Toxicol In Vitro. 2011 Feb;25(1):267-85
pubmed: 20828604
Toxicol Appl Pharmacol. 2010 May 15;245(1):57-66
pubmed: 20144636
Toxicol Sci. 2009 Aug;110(2):255-69
pubmed: 19447879
Mutat Res. 2020 May;853:503172
pubmed: 32522348
Chem Res Toxicol. 2016 Apr 18;29(4):659-68
pubmed: 26952143
Chem Res Toxicol. 2012 Nov 19;25(11):2352-67
pubmed: 22992039